Insight Molecular Diagnostics Inc. (IMDX)
NASDAQ: IMDX · Real-Time Price · USD
5.24
-0.34 (-6.09%)
At close: Dec 5, 2025, 4:00 PM EST
5.00
-0.24 (-4.58%)
After-hours: Dec 5, 2025, 5:06 PM EST
IMDX Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 150 | 40 | 21 | 38 | 200 | 161 | |
| Market Cap Growth | 250.12% | 94.02% | -45.76% | -80.98% | 24.52% | 25.25% | |
| Enterprise Value | 135 | 41 | 14 | 14 | 162 | 159 | |
| Last Close Price | 5.24 | 2.38 | 2.50 | 6.42 | 43.40 | 47.80 | |
| PS Ratio | 31.91 | 21.30 | 13.74 | 39.74 | 91.06 | 132.18 | |
| PB Ratio | - | -3.26 | 0.81 | 0.96 | 3.07 | 4.80 | |
| P/TBV Ratio | - | - | - | - | - | 17.31 | |
| EV/Sales Ratio | 30.59 | 21.64 | 9.60 | 15.07 | 73.75 | 130.37 | |
| Debt / Equity Ratio | -0.34 | -0.30 | 0.11 | 0.09 | 0.09 | 0.26 | |
| Debt / EBITDA Ratio | 0.01 | 0.01 | 0.00 | - | - | - | |
| Asset Turnover | 0.08 | 0.03 | 0.02 | 0.01 | 0.02 | 0.03 | |
| Quick Ratio | 2.47 | 1.41 | 1.38 | 1.85 | 2.50 | 0.89 | |
| Current Ratio | 2.79 | 1.62 | 1.49 | 2.11 | 2.77 | 1.03 | |
| Return on Equity (ROE) | -23603.11% | -910.86% | -76.26% | -35.52% | -88.37% | -93.07% | |
| Return on Assets (ROA) | -28.44% | -26.42% | -15.91% | -13.88% | -13.82% | -42.66% | |
| Return on Capital (ROIC) | -425.26% | -146.37% | -38.88% | -31.60% | -26.30% | -51.52% | |
| Return on Capital Employed (ROCE) | -71.60% | -83.60% | -32.90% | -32.80% | -16.30% | -70.00% | |
| Earnings Yield | -40.46% | -151.40% | -134.52% | -191.48% | -32.03% | -18.62% | |
| FCF Yield | -15.93% | -52.98% | -114.30% | -131.09% | -19.08% | -16.93% | |
| Buyback Yield / Dilution | -148.58% | -70.84% | -38.10% | -24.61% | -35.80% | -27.65% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.